TrialPloS one2015

Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy.

Miso Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.